MLD10 in the Prevention of Migraine in Adults
Clinical trial NCT02322333 · COMPLETED
Trial details
- NCT number
- NCT02322333
- Sponsor
- Pharmalyte Solutions LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.